Genetic Analysis   Report issue

For profit
Founded: Oslo Norway (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2018
NCT03586622
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Genetic Analysis AS

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 9